✦ LIBER ✦

Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1

✍ Scribed by Jin, Runyan; Cai, Ling; Tan, Ming; McHutchison, John G; Dowling, Thomas C; Howell, Charles D

Book ID: 120472251
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 291 KB
Volume: 107
Category: Article
ISSN: 0002-9270
DOI: 10.1038/ajg.2012.306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid virological response to peginterfe

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: The role of weight-based ribavirin exposure

✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Wan-Long Chuang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

contraindicate the use of drugs such as hydroxymethyl-glutaryl-coenzyme A inhibitors (statins). Statins, as the most popular cholesterollowering agents, are widely used in the MS and display in vitro anti-HCV properties. 6 However, results from an in vivo pilot study with atorvastatin have been disa

Treatment of chronic hepatitis C virus g

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

✍ Mitchell L. Shiffman; Jennifer Salvatore; Sarah Hubbard; Angie Price; Richard K. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

Impact of Ribavirin Dose Reductions in H

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

✍ Reddy, K. Rajender; Shiffman, Mitchell L.; Morgan, Timothy R.; Zeuzem, Stefan; H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 131 KB

68 RANDOMIZED CONTROLLED TRIAL OF NITAZO

68 RANDOMIZED CONTROLLED TRIAL OF NITAZOXANIDE-PEGINTERFERON-RIBAVIRIN, NITAZOXANIDE-PEGINTERFERON AND PEGINTERFERON-RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4

✍ J.F. Rossignol; A. Elfert; Y. El-Gohary; E.B. Keeffe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Peginterferon and Ribavirin Treatment in

Peginterferon and Ribavirin Treatment in African American and Caucasian American Patients With Hepatitis C Genotype 1

✍ Hari S. Conjeevaram; Michael W. Fried; Lennox J. Jeffers; Norah A. Terrault; The 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Safety and efficacy of peginterferon-rib

Safety and efficacy of peginterferon-ribavirin treatment in hepatitis C patients with heart disease

✍ E. Durante-Mangoni; D. Iossa; D. Pinto; R. Utili 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB